Today: 7 February 2026
Subscribe

Analog Devices Stock (ADI) Today, Dec. 22, 2025: Dividend Day, Fresh Analyst Targets, and What Could Drive the 2026 Outlook

Analog Devices Stock (ADI) Today, Dec. 22, 2025: Dividend Day, Fresh Analyst Targets, and What Could Drive the 2026 Outlook

Analog Devices, Inc. (NASDAQ: ADI) is ending the year with momentum—and Monday, December 22, 2025, gives investors a timely snapshot of why. The stock traded around $276 in U.S. session pricing, up roughly 0.6% on the day, with an intraday range near $275.49 to $278.14 and volume around 2.86 million shares. But today’s tape action is only part of the story. ADI is also paying its quarterly dividend today, coming off a strong fiscal Q4 earnings report and upbeat near-term guidance, while new analyst commentary and industry chatter are putting 2026 pricing power and AI-driven infrastructure demand back in the
22 December 2025
·····
Coca-Cola Stock Today: KO Holds Near $70 as CEO Transition, Dividend Focus, and 2026 Catalysts Shape the Outlook

Coca-Cola Stock Today: KO Holds Near $70 as CEO Transition, Dividend Focus, and 2026 Catalysts Shape the Outlook

December 22, 2025 — The Coca-Cola Company’s stock (NYSE: KO) is starting the holiday-shortened week in familiar fashion: steady, defensive, and in the spotlight for reasons that go beyond the day-to-day tape. Shares hovered around the $70 level on Monday, with trading reflecting a mix of long-term confidence in the company’s global brand engine and investor debate over valuation, leadership transition, and what 2026 could look like for consumer staples. StockAnalysis Below is a comprehensive roundup of the most current KO stock news, forecasts, and analysis circulating on December 22, 2025, along with the key drivers that could matter most
22 December 2025
·····
Lumen Technologies (LUMN) Stock News on Dec. 22, 2025: Tender Offer Changes, Debt Refinancing Push, and Updated Wall Street Outlook

Lumen Technologies (LUMN) Stock News on Dec. 22, 2025: Tender Offer Changes, Debt Refinancing Push, and Updated Wall Street Outlook

Lumen Technologies, Inc. (NYSE: LUMN) stock was in focus on Monday, Dec. 22, 2025, after the company disclosed early results and significant amendments to its previously announced cash tender offers for certain second-lien notes—a balance-sheet move investors often watch closely in leveraged telecom names. In afternoon trading, Lumen shares traded around $7.86, within a roughly $7.81–$8.36 intraday range. What’s driving the conversation today isn’t a shiny new product—it’s the less glamorous but very real world of debt management, which can matter a lot for equity holders when leverage is high and refinancing windows open and close like trapdoors. What Lumen
22 December 2025
····
TIM S.A. Stock (TIMS3, TIMB) on Dec. 22, 2025: Dividend Cutoff Day, Buyback-Driven Share Count Drop, and Fresh Analyst Targets for Brazil’s Telecom Leader

TIM S.A. Stock (TIMS3, TIMB) on Dec. 22, 2025: Dividend Cutoff Day, Buyback-Driven Share Count Drop, and Fresh Analyst Targets for Brazil’s Telecom Leader

Dec. 22, 2025 is a big calendar day for TIM S.A. stock—not because of a flashy product launch, but because it’s the shareholder “cutoff” date for a key portion of the company’s 2025 cash return program. TIM S.A. (the Brazilian telecom operator traded as TIMS3 on Brazil’s B3 exchange and TIMB as an ADR in the U.S.) is in the middle of an investor-friendly stretch: it has just confirmed a BRL 2.21 billion shareholder distribution (dividends + “interest on equity”), cancelled a meaningful block of treasury shares, and continues executing a multi-year plan that explicitly targets steady service-revenue growth, EBITDA
22 December 2025
····
Coinbase Global, Inc. (COIN) Stock Update: Prediction-Market Acquisition, “Everything Exchange” Rollout, and Analyst Forecasts on 22.12.2025

Coinbase Global, Inc. (COIN) Stock Update: Prediction-Market Acquisition, “Everything Exchange” Rollout, and Analyst Forecasts on 22.12.2025

Coinbase Global, Inc. (NASDAQ: COIN) is closing out December with a clear message to investors: it doesn’t want to be “just” a crypto exchange anymore. On Monday, 22.12.2025, Coinbase stock traded higher as the company announced another strategic deal—this time aimed at accelerating its expansion into prediction markets, one of the fastest-growing (and most contested) new corners of retail trading. Reuters As of 19:27 UTC on Dec. 22, COIN was at $249.45, up $4.33 (+1.77%) on the day, after touching an intraday high of $254.61. This move comes just days after Coinbase unveiled a broad “super app” strategy that blends
22 December 2025
·····
Inter & Co (INTR) Stock Slides on Dec. 22, 2025: Latest News, Analyst Price Targets, and What Investors Are Watching Next

Inter & Co (INTR) Stock Slides on Dec. 22, 2025: Latest News, Analyst Price Targets, and What Investors Are Watching Next

December 22, 2025 — Inter & Co, Inc. (NASDAQ: INTR) is back in the spotlight to start the holiday-shortened trading stretch, after the Brazilian digital bank and “super app” operator traded lower during Monday’s session. The move comes as investors digest a recent capital-markets update from the company’s banking subsidiary and weigh a wide spread of analyst price targets heading into 2026. MarketBeat+1 Below is a complete roundup of the current news, forecasts, and analyses available as of December 22, 2025, with context on what’s likely driving sentiment around INTR stock. What happened to INTR stock on December 22, 2025?
22 December 2025
····
Kyivstar Group Ltd Stock (NASDAQ: KYIV): News, Price Forecasts, and Analyst Outlook for December 22, 2025

Kyivstar Group Ltd Stock (NASDAQ: KYIV): News, Price Forecasts, and Analyst Outlook for December 22, 2025

December 22, 2025 — Kyivstar Group Ltd (NASDAQ: KYIV) has become one of the market’s most unusual telecom stories: a profitable, cash-generative operator in a war zone that’s simultaneously pitching itself as a “pure-play Ukraine” recovery investment and building resilience through satellite connectivity, backup power, and now—its own renewable generation. On Monday, December 22, KYIV shares traded around $13.14, down about 3.4% on the day, after opening near $13.73 and moving between roughly $13.10 and $13.76. That price action caps a choppy few sessions for the newly listed stock, which traded closer to $15 in mid-December before sliding back into
22 December 2025
·····
Dollar Tree Stock (DLTR) Today: Latest News, Analyst Forecasts, and What Could Drive Shares in 2026

Dollar Tree Stock (DLTR) Today: Latest News, Analyst Forecasts, and What Could Drive Shares in 2026

Dollar Tree, Inc. (NASDAQ: DLTR) stock is pulling back on Monday, December 22, 2025, after a powerful run that pushed the discount retailer near (and recently to) fresh 52-week highs earlier this month. Shares were trading around $122–$123, down roughly 4% on the day in late-morning/early-afternoon action—putting DLTR on lists of notable decliners even as broader markets held up. 24/7 Wall St.+1 That dip doesn’t come with a single, obvious “breaking headline” catalyst. Instead, it looks like a classic tension point for momentum retail names: upgraded earnings models and price targets on one side, valuation and “how sustainable is traffic?”
22 December 2025
··
Biogen (BIIB) Stock News Today (Dec. 22, 2025): QALSODY Data, Nasdaq-100 Exit, and Analyst Forecasts

Biogen (BIIB) Stock News Today (Dec. 22, 2025): QALSODY Data, Nasdaq-100 Exit, and Analyst Forecasts

Biogen Inc. (NASDAQ: BIIB) is in focus on Monday, December 22, 2025—a day that combines company-specific clinical headlines with a major index event for the stock. Investors are weighing fresh long‑term data for QALSODY (tofersen) in a rare genetic form of ALS, Biogen’s public statement honoring co‑founder Charles Weissmann, and the market mechanics of Biogen’s removal from the Nasdaq‑100, which becomes effective today. At the same time, Wall Street’s outlook remains mixed but active: recent analyst notes span “Reduce/Hold” to “Outperform” with price targets stretching from the low‑$140s to above $200, reflecting a debate over how quickly newer products—especially Leqembi
22 December 2025
·····
Stellantis Stock (STLA) Drops on Dec. 22, 2025: Latest News, Analyst Forecasts, and the 2026 Outlook

Stellantis Stock (STLA) Drops on Dec. 22, 2025: Latest News, Analyst Forecasts, and the 2026 Outlook

Stellantis N.V. stock (NYSE: STLA) traded lower on Monday, December 22, 2025, with shares hovering around $11.1 and down roughly 3%–4% on the session. Trading data showed an intraday range near $11.01 to $11.44 on volume of about 15 million shares, extending a choppy December stretch for the automaker’s U.S.-listed shares. StockAnalysis For investors, the day’s move lands in the middle of a bigger story: Stellantis is trying to rebuild momentum under CEO Antonio Filosa, while navigating policy uncertainty in Europe, shifting U.S. fuel-economy politics, ongoing recall headlines, and the market’s ongoing debate about margins, cash flow, and how quickly
22 December 2025
·····
Macy’s Stock (NYSE: M) Drops on Dec. 22, 2025: Analyst Downgrade, Turnaround Momentum, Dividend, and What Investors Watch Next

Macy’s Stock (NYSE: M) Drops on Dec. 22, 2025: Analyst Downgrade, Turnaround Momentum, Dividend, and What Investors Watch Next

Macy’s, Inc. stock (NYSE: M) slid on Monday, December 22, 2025, with shares down about 4% and trading around the $22.8 level after opening near $23.84 and dipping to the $22.76 area during the session. Investing.com The move comes as Wall Street continues to weigh two competing narratives around Macy’s stock: a real turnaround showing up in comparable sales and operating discipline, and a still-cautious near-term outlook shaped by a promotional holiday quarter, tariff-related cost pressure, and a retail consumer split where higher-income shoppers are holding up better than “aspirational” customers. Below is what’s driving Macy’s stock today, the most
22 December 2025
·····
Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Analyst Downgrades, and What Investors Watch Next (Dec. 22, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Analyst Downgrades, and What Investors Watch Next (Dec. 22, 2025)

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is trading like a classic “deal stock” on December 22, 2025—hovering just below a fixed cash acquisition price after BioMarin Pharmaceutical (NASDAQ: BMRN) agreed to buy the company in an all-cash transaction. As of the latest available trade on Dec. 22, FOLD is around $14.22, with the market effectively pricing in the probability, timing, and risk of the merger closing—rather than the stand-alone upside of Amicus’ rare disease commercial portfolio. Below is a detailed roundup of the current news, forecasts, and analyst/market commentary shaping Amicus stock on 22.12.2025—and the specific catalysts that can still move
22 December 2025
······
1 … 1,311 1,312 1,313 1,314 1,315 … 2,709

Stock Market Today

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop